278 related articles for article (PubMed ID: 22592077)
1. The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells.
Shimabukuro-Vornhagen A; Draube A; Liebig TM; Rothe A; Kochanek M; von Bergwelt-Baildon MS
J Exp Clin Cancer Res; 2012 May; 31(1):47. PubMed ID: 22592077
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
3. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
[TBL] [Abstract][Full Text] [Related]
5. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
6. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
[TBL] [Abstract][Full Text] [Related]
7. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.
Clatza A; Bonifaz LC; Vignali DA; Moreno J
J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847
[TBL] [Abstract][Full Text] [Related]
8. B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses.
Rossetti RAM; Lorenzi NPC; Yokochi K; Rosa MBSF; Benevides L; Margarido PFR; Baracat EC; Carvalho JP; Villa LL; Lepique AP
PLoS One; 2018; 13(7):e0199034. PubMed ID: 29975708
[TBL] [Abstract][Full Text] [Related]
9. Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B Cells.
Moore TC; Messer RJ; Gonzaga LM; Mather JM; Carmody AB; Bayer W; Littwitz-Salomon E; Dittmer U; Hasenkrug KJ
mBio; 2019 Jan; 10(1):. PubMed ID: 30670616
[TBL] [Abstract][Full Text] [Related]
10. CD40 activation of BCP-ALL cells generates IL-10-producing, IL-12-defective APCs that induce allogeneic T-cell anergy.
D'Amico G; Vulcano M; Bugarin C; Bianchi G; Pirovano G; Bonamino M; Marin V; Allavena P; Biagi E; Biondi A
Blood; 2004 Aug; 104(3):744-51. PubMed ID: 15001471
[TBL] [Abstract][Full Text] [Related]
11. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2.
Fayette J; Dubois B; Vandenabeele S; Bridon JM; Vanbervliet B; Durand I; Banchereau J; Caux C; Brière F
J Exp Med; 1997 Jun; 185(11):1909-18. PubMed ID: 9166420
[TBL] [Abstract][Full Text] [Related]
12. The properties of human CD40-activated B cells as antigen-presenting cells are not affected by PGE2.
Shimabukuro-Vornhagen A; Draube A; Liebig T; Popov A; Rothe A; von Bergwelt-Baildon M
Oncol Rep; 2013 Mar; 29(3):1061-5. PubMed ID: 23292511
[TBL] [Abstract][Full Text] [Related]
13. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
[TBL] [Abstract][Full Text] [Related]
14. Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
Carpenter EL; Mick R; Rüter J; Vonderheide RH
J Transl Med; 2009 Nov; 7():93. PubMed ID: 19906293
[TBL] [Abstract][Full Text] [Related]
15. Generation of human CD40-activated B cells.
Liebig TM; Fiedler A; Zoghi S; Shimabukuro-Vornhagen A; von Bergwelt-Baildon MS
J Vis Exp; 2009 Oct; (32):. PubMed ID: 19838159
[TBL] [Abstract][Full Text] [Related]
16. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
[TBL] [Abstract][Full Text] [Related]
17. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
[TBL] [Abstract][Full Text] [Related]
18. Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses.
Lee J; Dollins CM; Boczkowski D; Sullenger BA; Nair S
Immunology; 2008 Oct; 125(2):229-40. PubMed ID: 18393968
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10.
Rea D; van Kooten C; van Meijgaarden KE; Ottenhoff TH; Melief CJ; Offringa R
Blood; 2000 May; 95(10):3162-7. PubMed ID: 10807783
[TBL] [Abstract][Full Text] [Related]
20. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells.
Park JY; Yoon SH; Kim EK; Yun SO; Park MY; Sohn HJ; Kim TG
Immunol Lett; 2008 Feb; 116(1):33-40. PubMed ID: 18096249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]